"Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Substance (DS) facilities at Biocon Park, Bengaluru. These facilities, used for the manufacture of Biocon's portfolio of biosimilars, were inspected by the European agency in March 2019. This was a surveillance inspection of our existing DP and DS facilities and a pre-approval inspection of our additional DP manufacturing line. This certification will enable us to continue addressing the growing needs of patients in the EU markets and enhance access to our high quality biosimilars. We remain committed to global standards of quality and compliance." - Company Spokesperson.
Shares of BIOCON LTD. was last trading in BSE at Rs.248.9 as compared to the previous close of Rs. 256.4. The total number of shares traded during the day was 236587 in over 4240 trades.
The stock hit an intraday high of Rs. 259 and intraday low of 248. The net turnover during the day was Rs. 59374043.